000153220 001__ 153220
000153220 005__ 20240229123042.0
000153220 0247_ $$2doi$$a10.1186/s12885-019-6452-0
000153220 0247_ $$2pmid$$apmid:31964352
000153220 0247_ $$2altmetric$$aaltmetric:74434549
000153220 037__ $$aDKFZ-2020-00260
000153220 041__ $$aeng
000153220 082__ $$a610
000153220 1001_ $$00000-0002-3837-8477$$aFeller, Anita$$b0
000153220 245__ $$aThe relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study.
000153220 260__ $$aHeidelberg$$bSpringer$$c2020
000153220 3367_ $$2DRIVER$$aarticle
000153220 3367_ $$2DataCite$$aOutput Types/Journal article
000153220 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1636021659_8627
000153220 3367_ $$2BibTeX$$aARTICLE
000153220 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000153220 3367_ $$00$$2EndNote$$aJournal Article
000153220 520__ $$aMore people than ever before are currently living with a diagnosis of cancer and the number of people concerned is likely to continue to rise. Cancer survivors are at risk of developing a second primary cancer (SPC). This study aims to investigate the risk of SPC in Switzerland.The study cohort included all patients with a first primary cancer recorded in 9 Swiss population-based cancer registries 1981-2009 who had a minimum survival of 6 months, and a potential follow-up until the end of 2014. We calculated standardized incidence ratios (SIR) to estimate relative risks (RR) of SPC in cancer survivors compared with the cancer risk of the general population. SIR were stratified by type of first cancer, sex, age and period of first diagnosis, survival period and site of SPC.A total of 33,793 SPC were observed in 310,113 cancer patients. Both male (SIR 1.18, 95%CI 1.16-1.19) and female (SIR 1.20, 95%CI 1.18-1.22) cancer survivors had an elevated risk of developing a SPC. Risk estimates varied substantially according to type of first cancer and were highest in patients initially diagnosed with cancer of the oral cavity and pharynx, Hodgkin lymphoma, laryngeal, oesophageal, or lung cancer. Age-stratified analyses revealed a tendency towards higher RR in patients first diagnosed at younger ages. Stratified by survival period, risk estimates showed a rising trend with increasing time from the initial diagnosis. We observed strong associations between particular types of first and SPC, i.e. cancer types sharing common risk factors such as smoking or alcohol consumption (e.g. repeated cancer of the oral cavity and pharynx (SIRmales 20.12, 95%CI 17.91-22.33; SIRfemales 37.87, 95%CI 30.27-45.48).Swiss cancer survivors have an increased risk of developing a SPC compared to the general population, particularly patients first diagnosed before age 50 and those surviving more than 10 years. Cancer patients should remain under continued surveillance not only for recurrent cancers but also for new cancers. Some first and SPCs share lifestyle associated risk factors making it important to promote healthier lifestyles in both the general population and cancer survivors.
000153220 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000153220 588__ $$aDataset connected to CrossRef, PubMed,
000153220 7001_ $$aMatthes, Katarina L$$b1
000153220 7001_ $$aBordoni, Andrea$$b2
000153220 7001_ $$aBouchardy, Christine$$b3
000153220 7001_ $$aBulliard, Jean-Luc$$b4
000153220 7001_ $$aHerrmann, Christian$$b5
000153220 7001_ $$aKonzelmann, Isabelle$$b6
000153220 7001_ $$aMaspoli, Manuela$$b7
000153220 7001_ $$aMousavi, Mohsen$$b8
000153220 7001_ $$aRohrmann, Sabine$$b9
000153220 7001_ $$aStaehelin, Katharina$$b10
000153220 7001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b11$$udkfz
000153220 7001_ $$aGroup, NICER Working$$b12$$eCollaboration Author
000153220 7001_ $$aStaehelin, K.$$b13
000153220 7001_ $$aBouchardy, C.$$b14
000153220 7001_ $$aMousavi, M.$$b15
000153220 7001_ $$aBulliard, J. L.$$b16
000153220 7001_ $$aMaspoli, M.$$b17
000153220 7001_ $$aMousavi, M.$$b18
000153220 7001_ $$aBordoni, A.$$b19
000153220 7001_ $$aKonzelmann, I.$$b20
000153220 7001_ $$aBlanc-Moya, R.$$b21
000153220 7001_ $$aRohrmann, S.$$b22
000153220 773__ $$0PERI:(DE-600)2041352-X$$a10.1186/s12885-019-6452-0$$gVol. 20, no. 1, p. 51$$n1$$p51$$tBMC cancer$$v20$$x1471-2407$$y2020
000153220 909CO $$ooai:inrepo02.dkfz.de:153220$$pVDB
000153220 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000153220 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000153220 9141_ $$y2020
000153220 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMC CANCER : 2017
000153220 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000153220 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000153220 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000153220 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000153220 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000153220 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000153220 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review
000153220 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000153220 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000153220 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000153220 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000153220 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000153220 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000153220 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000153220 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000153220 9201_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000153220 980__ $$ajournal
000153220 980__ $$aVDB
000153220 980__ $$aI:(DE-He78)C071-20160331
000153220 980__ $$aUNRESTRICTED